Browsing Category
Pharma Industry News
4745 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Breckenridge Pharmaceutical receives FDA approval for dehydrated alcohol injection, strengthening its institutional strategy
Breckenridge secures FDA approval for its generic dehydrated alcohol injection, boosting institutional reach for cardiac therapy. Read more on market strategy.
ImmunoPrecise (NASDAQ: IPA) validates AI-discovered universal dengue vaccine target with confirmed safety, immune activation, and structural stability
ImmunoPrecise (NASDAQ: IPA) validates AI-engineered dengue vaccine with confirmed immune activation, safety, and stability, marking a new era in AI-driven drug discovery.
How Novo Nordisk is building a post-semaglutide strategy: Inside its metabolic pipeline and innovation bets
Novo Nordisk pivots beyond semaglutide with amycretin, CagriSema, and oral GLP-1 therapies. See how it’s building its next-generation obesity drug platform.
Portal Biotechnologies awarded $8m DARPA contract to create portable red blood cell therapy system for rapid field-based treatment
Portal Biotechnologies secures $8M DARPA contract to build a field-deployable red blood cell therapy device using mechanoporation technology.
NeoGenomics appoints Merck oncology executive Dr. Marjorie Green to its board to advance leadership in precision diagnostics
NeoGenomics adds Merck oncology leader Dr. Marjorie Green to board, strengthening its precision diagnostics strategy and global pharmaceutical partnerships.
Tandem Diabetes Care expands insulin pump integration with Abbott’s FreeStyle Libre 3 Plus sensor for U.S. diabetes patients
Tandem Diabetes Care integrates t:slim X2 insulin pump with Abbott’s FreeStyle Libre 3 Plus in the U.S., advancing automated insulin delivery personalization.
Can Dr. Reddy’s build a biosimilars portfolio that rivals Biocon and global MNCs in regulated markets?
Explore Dr. Reddy’s biosimilars pipeline, regulatory milestones, and commercial strategy—can it compete with Biocon and global pharma giants in 2025?
Will CABOMETYX secure EU approval for advanced neuroendocrine tumors after CHMP’s positive opinion?
Ipsen’s CABOMETYX receives EMA's CHMP backing for advanced neuroendocrine tumors; EU approval expected in 2025 following FDA nod.
Candid Therapeutics launches first-in-class T-cell engager trials across five autoimmune diseases
Candid Therapeutics begins Phase 1 trials of BCMA and CD20 T-cell engagers across five autoimmune diseases; institutional interest builds around TCE approach.
Atrogi’s ATR-258 breakthrough: muscle-targeted β2-agonist mimics exercise to treat obesity, diabetes, and muscle loss
Atrogi’s ATR-258 mimics exercise through skeletal muscle targeting to reduce fat and preserve muscle, redefining obesity and diabetes therapies.